Perseus-Soros Biopharmaceutical Fund - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Perseus-Soros Biopharmaceutical Fund

investment firm

Summary
Founds Raised
Investments
Exits

About

Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.

New York,New York,United States

Highlights

Lead Investments

Details

Operating Status: Active
Investor Type: PE

Funds Raised

Announced Date	Fund Name		Money Raised
Jan 1, 2000	Perseus-Soros BioPharmaceutical Fund		$449M

Investments

Number of Investments

Number of Lead Investments

22

5

Perseus-Soros Biopharmaceutical Fund has made 22 investments. Their most recent investment was on Oct 30, 2009, when Xanodyne raised $87.78M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 30, 2009 Xanodyne	Series Unknown	$87.78M	Biotechnology	—
Sep 29, 2008 CeNeRx BioPharma	Series B	$15M	Biopharma	—
Nov 14, 2007 Ambit Biosciences	Series D	$49.30M	Biopharma	—
May 1, 2006 Cardiokine	Series B	$50M	Biotechnology	—
Apr 12, 2006 SkinMedica	Series E	$11M	Biotechnology	—

Show More

Exits

Perseus-Soros Biopharmaceutical Fund has had 9 exits. Perseus-Soros Biopharmaceutical Fund most notable exits include Ambit Biosciences , SkinMedica

Date	Company Name	Exit Type	Industry
May 16, 2013	Ambit Biosciences	M&A	Biopharma	Detail
Nov 16, 2012	SkinMedica	M&A	Biotechnology	Detail
Jan 4, 2012	Cardiokine	M&A	Biotechnology	Detail
Oct 26, 2011	Advion Inc.	M&A	Biotechnology	Detail
May 27, 2010	Aton Pharma	M&A	Biotechnology	Detail

Show More